|
Fatemeh Mosaffa Address: Department of Pharmaceutical Biotechnology, Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran Tel: 0098-51-31801536 Fax: 0098-51-38823251 Postal code: 1365- 91775 Email: این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید; این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید
Educational Background
Thesis title: Evaluation of the effects of pro-inflammatory cytokines on BCRP gene expression and function in human cancer cell lines Supervisor: Dr. Javad Behravan, School of Pharmacy, Waterloo Centre for Microbial Research, University of Waterloo, Canada
Supervisor: Dr. He rmann Lage, Charité - Universitätsmedizin Berlin, Charité Campus Mitte, Institute of Pathology, Berlin, Germany
Thesis title: Effect of particle size, compaction force and presence of Aerosil 200 on the properties of matrices prepared from physical mixture of Propranolol Hydrochloride and Eudragit RS or RL
Supervisor: Dr. Fatemeh Sadeghi, Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Awards
Professional Experience
Research interest Gene Regulation in Cancer, Drug resistance in cancer, Inflammation and cancer, Natural products
Administrative Responsibilities
Teaching Experience Molecular biology, Pharmaceutical biotechnology, Biological product, Genetic engineering
Membership
Languages
Publications 1- Abdi H, Aganj Z, Hosseinzadeh H, Mosaffa F*. Crocin restores the balance of Th1/Th2 immune cell response in ConA-treated human lymphocytes. Pharmacol Rep. 2022 Jun;74(3):513-522. 2- Dahmardeh Ghalehno A, Boustan A, Abdi H, Aganj Z, Mosaffa F*, Jamialahmadi K.The Potential for Natural Products to Overcome Cancer Drug Resistance by Modulation of Epithelial-Mesenchymal Transition. Nutr Cancer. 2022 Jan 7:1-27. 3- PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients. Jahangiri R, Mosaffa F, Emami Razavi A, Teimoori-Toolabi L, Jamialahmadi K. J Oncol Pharm Pract. 2022 Mar;28(2):310-325. 4- Jahangiri R, Mosaffa F, Emami Razavi A, Teimoori-Toolabi L, Jamialahmadi K. PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients. J Oncol Pharm Pract. 2022 Mar;28(2):310-325 5- Mosaffa F, Hadizadeh F, Fathi F, Eslami Nasab Z, Pourzahed T, Aboutorabzade SM, Ghodsi R.Synthesis and biological evaluation of novel quinoline analogs of ketoprofen as multidrug resistance protein 2 (MRP2) inhibitors. Iran J Basic Med Sci. 2021 Jun;24(6):815-825. 6- Rahimzadeh Oskuei S, Mirzaei S, Reza Jafari-Nik M, Hadizadeh F, Eisvand F, Mosaffa F, Ghodsi R. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors. Bioorg Chem. 2021 Jul;112:104904. 7- Boustan A, Mosaffa F, Jahangiri R, Heidarian-Miri H, Dahmardeh-Ghalehno A, Jamialahmadi K. Role of SALL4 and Nodal in the prognosis and tamoxifen resistance of estrogen receptor-positive breast cancer. Mol Biol Res Commun. 2021 Sep;10(3):109-119. 8- Valinezhad Sani F, Alamolhodaei NS, Rashidpoor H, Gharaee ME, Behravan J, Mosaffa F. The effect of IL-1β on MRP2 expression and tamoxifen toxicity in MCF-7 breast cancer cells. Breast Dis. 2021;40(4):263-268. 9- Shakour N, Sahebkar A, Karimi G, Paseban M, Tasbandi A, Mosaffa F, Tayarani-Najaran Z, Ghodsi R, Hadizadeh F. Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents. Bioorg Chem. 2021 Oct;115:105162. 10- Valinezhad Sani F, Palizban A, Mosaffa F*, Jamialahmadi K. Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells. J Pharm Pharmacol. 2021 Jun 8;73(7):922-927. 11- Valinezhad Sani F, Mosaffa F, Jamialahmadi K, Palizban A. Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells. Nutr Cancer. 2020;72(3):522-527. 12- Mirzaei S, Eisvand F, Hadizadeh F, Mosaffa F, Ghasemi A, Ghodsi R. Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors. Bioorg Chem. 2020 May;98:103711. 13- Mirzaei S, Eisvand F, Hadizadeh F, Mosaffa F, Ghodsi R. Design, synthesis, and biological evaluation of novel 5,6,7-trimethoxy quinolines as potential anticancer agents and tubulin polymerization inhibitors. Iran J Basic Med Sci. 2020 Dec;23(12):1527-1537. 14- Norouzi S, Yazdian Robati R, Ghandadi M, Abnous K, Behravan J, Mosaffa F*. Comparative proteomics study of proteins involved in induction of higher rates of cell death in mitoxantrone-resistant breast cancer cells MCF-7/MX exposed to TNF-α. Iran J Basic Med Sci. 2020 May;23(5):663-672. 15- Jahangiri R, Mosaffa F, EmamiRazavi A, Gharib M, Jamialahmadi K. Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma Patients. Pathol Oncol Res. 2020 Jul;26(3):1921-1934. 16- Valinezhad Sani F, Palizban A, Mosaffa F*, Jamialahmadi K. Glucosamine reverses drug resistance in MRP2 overexpressing ovarian cancer cells. Eur J Pharmacol. 2020 Feb 5;868:172883. 17- Jahangiri R, Jamialahmadi K, Gharib M, Emami Razavi A, Mosaffa F*. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients. Gene. 2019 Feb 15;685:24-31. 18- Ghandadi M, Behravan J, Abnous K, Ehtesham Gharaee M, Mosaffa F*. TNF-α exerts cytotoxic effects on multidrug resistant breast cancer MCF-7/MX cells via a non-apoptotic death pathway. Cytokine. 2017 Sep; 97:167-174. 19- Norouzi S, Yazdian R, Ghanaian M, Abnous K, Behravan J, Mosaffa F*. Comparative proteomics study of proteins involved in induction of higher rates of cell death in mitoxantrone-resistant breast cancer cells MCF-7/MX exposed to TNF-α. Iranian Journal of Basic Medical Sciences 23 (5), 663-672. 20- Ghandadi M, Behravan J, Biabani S, Abaspor S, Mosaffa F*. MCF-7 and its Multidrug Resistant Variant MCF-7/ADR Overcome TNF Cytotoxicity through Prevention of Reactive Oxygen Species Accumulation. Pharm Sci. 2019 ;25(2): 118-123. 21-Jahangiri R, Mosaffa F, EmamiRazavi A, Gharib M, Jamialahmadi K. Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma Patients. Pathol Oncol Res. 2019 Dec 18. [Epub ahead of print] 22- Razazan A, Nicastro J, Slavcev R, Barati N, Arab A, Mosaffa F, Jaafari MR, Behravan J. Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice. Sci Rep. 2019 Feb 18;9(1):2221. 23- Mirzaei S, Hadizadeh F, Eisvand F, Mosaffa F, R Ghodsi. Synthesis, structure-activity relationship and molecular docking studies of novel quinoline-chalcone hybrids as potential anticancer agents and tubulin inhibitors. J Molecular Structure. 2019, 127310. 24- Valinezhad Sani F, Mosaffa F, Jamialahmadi K, Palizban A.Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells. Nutr Cancer. 2019 Jul 10:1-6. 25- Norouzi S, Gorgi Valokala M, Mosaffa F, Zirak MR, Zamani P, Behravan J. Crosstalk in cancer resistance and metastasis. Crit Rev Oncol Hematol. 2018 Dec; 132:145-153. Review. 26- Arab A, Behravan N, Razazn A, Barati N, Mosaffa F, Nicastro J, Slavcev R, Behravan J. The viral approach to breast cancer immunotherapy. J Cell Physiol. 2019 Feb;234(2):1257-1267. 27- Jahangiri R, Mosaffa F, Gharib M, Emami Razavi AN, Abdirad A, Jamialahmadi K. PAX2 expression is correlated with better survival in tamoxifen-treated breast carcinoma patients. Tissue Cell. 2018 Jun; 52:135-142. 28- Barati N, Razazan A, Nicastro J, Slavcev R, Arab A, Mosaffa F, Nikpoor AR, Badiee A, Jaafari MR, Behravan J. Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice. Cancer Lett. 2018 Jun 28; 424:109-116. 29- Jahangiri R, Mosaffa F, Emami Razavi A, Teimoori-Toolabi L, Jamialahmadi K. Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors. J Cell Physiol. 2018 Sep;233(9):7305-7319. 30- Aboutorabzadeh SM, Mosaffa F, Hadizadeh F, Ghodsi R. Design, synthesis, and biological evaluation of 6-methoxy-2-arylquinolines as potential P-glycoprotein inhibitors. Iran J Basic Med Sci. 2018 Jan;21(1):9-18. 31- Arab A, Nicastro J, Slavcev R, Razazan A, Barati N, Nikpoor AR, Brojeni AAM, Mosaffa F, Badiee A, Jaafari MR, Behravan J. Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response. Immunol Res. 2018 Feb;66(1):200-206. 32- Razazan A, Behravan J, Arab A, Barati N, Arabi L, Gholizadeh Z, Hatamipour M, Reza Nikpoor A, Momtazi-Borojeni AA, Mosaffa F, Ghahremani MH, Jaafari MR. Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model. PLoS One. 2017 Oct 18;12(10): e0185099. 33- Arab A, Behravan J, Razazan A, Gholizadeh Z, Nikpoor AR, Barati N, Mosaffa F, Badiee A, Jaafari MR. A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice. J Drug Target. 2018 Apr;26(4):365-372. 34- Barati N, Nikpoor AR, Razazan A, Mosaffa F, Badiee A, Arab A, Gholizadeh Z, Behravan J, Jaafari MR. Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer. Immunol Lett. 2017 Oct; 190:108-117. 35- Nabavinia MS, Charbgoo F, Alibolandi M, Mosaffa F, Gholoobi A, Ramezani M, Abnous K. Comparison of Flow Cytometry and ELASA for Screening of Proper Candidate Aptamer in Cell-SELEX Pool. Appl Biochem Biotechnol. 2018 Feb;184(2):444-452. 36- Jabini R, Ehtesham-Gharaee M, Dalirsani Z, Mosaffa F*, Delavarian Z, Behravan J. Evaluation of the Cytotoxic Activity of Crocin and Safranal, Constituents of Saffron, in Oral Squamous Cell Carcinoma (KB Cell Line). Nutr Cancer. 2017 Aug-Sep;69(6):911-919. 37- Ghandadi M, Mohammadi A, Behravan J, Abnous K, Haj-Ali N, Gharaee ME, Mosaffa F*. Inhibition of Akt phosphorylation attenuates resistance to TNF-α cytotoxic effects in MCF-7 cells, but not in their doxorubicin resistant derivatives. Iran J Basic Med Sci. 2016 Dec;19(12):1363-1367. 38- Alamolhodaei NS, Behravan J, Mosaffa F, Karimi G. MiR 221/222 as New Players in Tamoxifen Resistance. Curr Pharm Des. 2016;22(46):6946-6955. 39- Kamrani M, Mosaffa F, Behravan J, Lage H, Hadizadeh F. P-gp and BCRP inhibition induced by some new 1,4 dihydropyridine and dihydropyrimidines. International Journal of Bioinformatics Research and Applications. Int. J. Bioinformatics Research and Applications. 2017, 13(1): 62-74. 40- Shobeiri N, Rashedi M, Mosaffa F, Zarghi A, Ghandadi M, Ghasemi A, Ghodsi R. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors. Eur J Med Chem. 2016 Mar 2; 114:14-23. (IF: 3.447) 41- Ghandadi M, Behravan J, Abnous K, Mosaffa F*. Reactive Oxygen Species Mediate TNF-α; Cytotoxic Effects in the Multidrug-Resistant Breast Cancer Cell Line MCF-7/MX. Oncol Res Treat. 2016;39(1-2):54-9. 42- Taghavi S, HashemNia A, Mosaffa F, Askarian S, Abnous K, Ramezani M. Preparation and evaluation of polyethylenimine-functionalized carbon nanotubes tagged with 5TR1 aptamer for targeted delivery of Bcl-xL shRNA into breast cancer cells. Colloids Surf B Biointerfaces. 2016 Apr 1; 140:28-39. (IF: 4.152) 43- Kasaian J, Mosaffa F*, Behravan J, Masullo M, Piacente S, Iranshahi M. Modulation of Multidrug Resistance Protein 2 Efflux in the Cisplatin Resistance Human Ovarian Carcinoma Cells A2780/RCIS by Sesquiterpene Coumarins. Phytother Res. 2016 Jan;30(1):84-9. (IF: 2.66) 44- Arabi L, Badiee A, Mosaffa F, Jaafari MR. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin. J Control Release. 2015 Dec 28;220(Pt A):275-86. (IF: 7.705) 45- Ghandadi M, Haj-Ali N, Behravan J, Abnous K, Mohammadi A, Gharaee ME, Mosaffa F*. TNF-α exerts higher cytotoxic effect on MCF-7 multidrug resistant derivative, role of Akt activation. Breast Dis. 2015 Nov 17;35(4):241-7. 46- Kasaian J, Mosaffa F, Behravan J, Masullo M, Piacente S, Ghandadi M, Iranshahi M. Reversal of P-glycoprotein-mediated multidrug resistance in MCF-7/Adr cancer cells by sesquiterpene coumarins. Fitoterapia. 2015; Jun; 103:149-54. 47- Moosavian SA, Jaafari MR, Taghdisi SM, Mosaffa F, Badiee A, Abnous K. Development of RNA aptamers as molecular probes for HER2+ breast cancer study using cell-SELEX. Iran J Basic Med Sci. 2015; Jun;18(6):576-86. 48- Mohammadi M, Salmasi Z, Hashemi M, Mosaffa F, Abnous K, Ramezani M. Single-walled carbon nanotubes functionalized with aptamer and piperazine–polyethylenimine derivative for targeted siRNA delivery into breast cancer cells. International journal of pharmaceutics. Int J Pharm. 2015; May 15;485(1-2):50-60. 49- Nourbakhsh M, Jaafari MR, Lage H, Abnous K, Mosaffa F, Badiee A, Behravan J. Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer. Iran J Basic Med Sci. 2015; Apr;18(4):385-92. 50- Ehtesham-Gharaee M, Eshaghi A, Shojaee S, Asili J, Emami SA, Behravan J, Mosaffa F*. Protective effects of Scutellaria lindbergii root extract against oxidative-induced cell and DNA damage in mouse fibroblast-like cells. Drug Chem Toxicol. 2015; Jul;38(3):293-9. 51- Kalalinia F, Elahian F, Mosaffa F, Behravan J. Celecoxib up regulates the expression of drug efflux transporter ABCG2 in breast cancer cell lines. Iranian Journal of Pharmaceutical Research. 2014; 13: 1391-1399. 52- Moayedian T, Mosaffa F, Khameneh B, Tafaghodi M. Combined effects of PEGylation and particle size on uptake of PLGA particles by macrophage cells. Nanomedicine Journal.2015; 2 (4), 299-304. 53- Nourbakhsh M, Behravan J, Lage H, Abnous K, Badiee A, Mosaffa F, Jaafari M R . Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization and cellular uptake. Nanomedicine Journal. 2015; 2 (1), 39-45 54- Shojaee S, Parhiz H, Eshaghi A, Emami SA, Asili J, Behrabvan J, Mosaffa F*. In vitro protective effects of Scutellaria litwinowi root extract against H2O2-induced DNA damage and cytotoxicity. J Complement Integr Med. 2014; Jun;11(2):121-7. 55- Razavi-Azarkhiavi K, Behravan J, Mosaffa F, Sehatbakhsh S, Shirani K, Karimi G. Protective effects of aqueous and ethanol extracts of rosemary on H 2O2-induced oxidative DNA damage in human lymphocytes by comet assay. J Complement Integr Med. 2014; Feb 4; 11:27-33. 56- Jabini R, Moradi A, Afsharnezhad S, Ayatollahi H, Behravan J, Raziee HR, Mosaffa F*. Pathodiagnostic parameters and evaluation of O(6)- methyl guanine methyl transferase gene promoter methylation in meningiomas. Gene. 2014; Apr 1;538(2):348-53 57- Jamialahmadi K, Soltani F, Nabavi fard M, Behravan J, Mosaffa F *. Assessment of protective effects of glucosamine and N-acetyl glucosamine against DNA damage induced by hydrogen peroxide in human lymphocytes. Drug and chemical toxicology. 2014; 37 (4): 427-432 58- Zarei H, Rezaee R, Behravan E, Soltani F, Mosaffa F, Iranshahi M, Behravan J. Farnesiferol A from Diversin, from Ferula diversivittata protects human lymphocytes against oxidative stress induced by H(2)O(2). Nat Prod Res. 2013; 27 (11): 1016 – 1019. 59- Shirani K, Behravan J, Mosaffa F, Iranshahi M, Mehmankhah B, Razavi-Azarkhiavi K, Karimi Gh. Evaluating the effects of galbanic acid on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Avecina Journal of Phytomedicine (AJP), 2014, Jan 25, Epub ahead of print. 60- Taghiabadi E, Imenshahidi M, Abnous K, Mosafa F, Sankian M, Memar B, Karimi G. Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice. Evid Based Complement Alternat Med. 2012; 2012:352091. 61- Mosaffa F*, Kalalinia F, Lage H, Afshari JT, Behravan J. Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells. Mol Cell Biochem. 2012; Apr; 363(1-2):385-93. 62- Hanafi-Bojd MY, Iranshahi M, Mosaffa F, Tehrani SO, Kalalinia F, Behravan J. Farnesiferol A from Ferula persica and Galbanic Acid from Ferula szowitsiana Inhibit P-Glycoprotein-Mediated Rhodamine Efflux in Breast Cancer Cell Lines. Planta Med. 2011; 77(14):1590-3. 63- Mosaffa F, Kalali Nia F, Parhiz H, Behravan J. Tumor Necrosis Factor Alpha induces stronger cytotoxicity in ABCG2-overexpressing resistant breast cancer cells compared to their drug-sensitive parental line; DNA Cell Biol. 2011;30(6):413-8. 64- Hosseinzadeh L, Behravan J, Mosaffa F, Bahrami G, Bahrami A, Karimi G. Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species. Food Chem Toxicol. 2011; 49 (5):1102-9. 65- Behravan J, Mosafa F, Soudmand N, Taghiabadi E, Razavi BM, Karimi G. Protective effects of aqueos and ethanoloc extracts of Porulacea L. aerial parts on H2O2 induced DNA damage in lymphocytes by comet assay. J Acupunct Meridian Stud. 2011; 4(3):193-197. 66- Hosseinzadeh L, Behravan J, Mosaffa F, Bahrami G, Bahrami A, Karimi G. Effect of Curcumin on Doxorubicin-induced Cytotoxicity in H9c2 Cardiomyoblast Cells. Iran J Basic Med Sci. 2011; 14(1): 49-56. 67- Malekshah OM, Bahrami, AR, Afshari JT, Mosaffa F, Behravan J. Correlation between PXR and ABCG2 patterns of mRNA expression in a MCF7 breast carcinoma cell derivative upon induction by proinflammatory cytokines. DNA Cell Biol. 2011; 30(1):25-31. 68- Taghdisi M, Abnous k, Mosaffa F, Behravan, J. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer. J Drug Target. 2010; 18(4):277-81. 69- Soltani F, Mosaffa F, Iranshahi M, Karimi G, Malekaneh M, Haghighi F, Behravan J. Auraptene from Ferula szowitsiana protects human peripheral lymphocytes against oxidative stress. Phytother Res. 2010; 24(1):85-9. 70- Sabahi Z, Salek R, Heravi RE, Mosaffa F, Avanaki ZJ, Behravan J. Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian Journal of Cancer. 2010; 47(3):317-321. 71- Tatari F, Salek R, Mosaffa F, Behravan J. Association of C3435T single nucleotide polymorphism of MDR1 gene with breast cancer in the Iranian population. DNA Cell Biol. 2009; 28(5):259-63. 72- Mosaffa F, Lage H, Tavakol Afshari J, Behravan J. Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX. Inflamm Res. 2009; 58(10):669-76. 73- Noroozi S, Mosaffa F, Soltani F, Iranshahi M, Karimi G, Malekaneh M, Haghighi F, Behravan J. Antigenotoxic Effects of the Disulfide Compound Persicasulfide A (PSA) on Rat Lymphocytes Exposed to Oxidative Stress. Planta Med. 2009; 75(1):32-6. 74- Soltani F, Mosaffa F, Iranshahi M, Karimi G, Malekaneh M, Haghighi F, Behravan J. Evaluation of antigenotoxicity effects of umbelliprenin on human peripheral lymphocytes exposed to oxidative stress. Cell Biol Toxicol. 2009; 25(3):291. 75- Sadeghi F, Mosaffa F, Afrasiabi Garekani H. Effect of particle size, compaction force and presence of aerosol 200 on the properties of matrices prepared from physical mixture of propranolol hydrochloride and eudragit RS and RL. Iranian Journal of Basic Medical Sciences. 2007; 10(3):197-205.) 76- Mosaffa F, Behravan G, Karimi, Iranshahi M. Antigenotoxic Effects of Satureja hortensis L. on Rat Lymphocytes Exposed to Oxidative Stress. Arch Pharm Res. 2006; 29 (2):159-64.
Presentations
|